Direct Patient Home Delivery is a type of decentralized clinical trial in which some aspects of the trial are conducted outside of the investigator's location (eg, patient's home, workplace, travel destination).
In clinical trials, the Direct to Patient model allows drug treatments to be administered and administered at the patient's home and/or the collection and removal of biological samples from the patient's home. Depending on the complexity of trial protocols, patients may take medications themselves or rely on a home care nurse or caregiver for clinical support. Because the Direct to Patient model allows the patient to participate in a clinical trial from home, it reduces the need for the patient to travel to the investigator's location, increases the likelihood of agreeing to participate, and reduces the likelihood of dropout.
DtP Patient Model
Tunaset; Within the scope of Clinical Research studies, delivery of temperature-controlled drugs to multinational projects from a single country and to patient homes; It is extremely collaborative in the creation of Direct-to-Patient projects of all shapes and sizes, from residential to patient sampling. Often there is more than one party involved, from sponsors or manufacturers to CROs or other teams handling project and study requirements, as well as pharmacies to laboratories. Firms undertaking this work are often a focal point, coordination and communication point for Tunaset, as nurses visit patients' homes and often schedule visits that require the delivery of drugs, the collection of samples or the return of drugs. The Tunaset network is particularly advantageous in this regard as its collection and delivery points can be spread over a wide geographical area. Every flight or extra step that can be missed significantly increases the risk or delays for the product. In order to reduce these risks, Tunaset's experienced Logistics team is always at the service of companies and patients.
